Through pan-cancer analysis, we found that, unlike other tumor markers that are always highly or lowly expressed in different tumors, CSRP1 shows different expression patterns between different tumors, with CSRP1 highly expressed in 7 cancers and lowly expressed in 18 tumors. Here, CSRP1 is linked to neoplasm.